NYSE : PEN

Penumbra, Inc. — Company profile

Healthcare · Medical Devices · United States

Last price 321.97 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 12.68B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Details

NamePenumbra, Inc.
SectorHealthcare
IndustryMedical Devices
Employees4700
Founded2004
Ipo Date2015-09-18
CeoAdam Elsesser
CountryUnited States
ExchangeNYSE
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS70975L1070
Cusip70975L107
Cik0001321732
Sic3841
Stock TypeCommon Stock

Key executives

NameTitle
Adam Elsesser J.D.Co-Founder, Chairman and Chief Executive Officer
Shruthi NarayanPresident
Dr. Arani Bose M.D.Co-Founder and Director
Maggie S. YuenChief Financial Officer
Lambert ShiuChief Accounting Officer
Johanna Roberts J.D.Executive Vice President, General Counsel and Secretary
Ben SorciExecutive Vice President of Operations
Jee Hamlyn-HarrisInvestor Relations Officer
Ben TompkinsExecutive Vice President of Development and Compliance
Jason Richard MillsExecutive Vice President of Strategy

Contact

AddressOne Penumbra Place, Alameda, California 94502, United States
Phone510 748 3200
Websitehttps://www.penumbrainc.com